Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma

Blood. 2007 May 1;109(9):3849-55. doi: 10.1182/blood-2006-11-056879. Epub 2007 Jan 16.

Abstract

Defects in apoptosis mechanisms play important roles in malignancy and autoimmunity. Orphan nuclear receptor Nur77/TR3 has been demonstrated to bind antiapoptotic protein Bcl-2 and convert it from a cytoprotective to a cytodestructive protein, representing a phenotypic conversion mechanism. Of the 6 antiapoptotic human Bcl-2 family members, we found that Nur77/TR3 binds strongest to Bcl-B, showing selective reactivity with Bcl-B, Bcl-2, and Bfl-1 but not Bcl-X(L), Mcl-1, or Bcl-W. Nur77 converts the phenotype of Bcl-B from antiapoptotic to proapoptotic. Bcl-B is prominently expressed in plasma cells and multiple myeloma. Endogenous Bcl-B associates with endogenous Nur77 in RPMI 8226 myeloma cells, where RNA interference experiments demonstrated dependence on Bcl-B for Nur77-induced apoptosis. Furthermore, a Nur77-mimicking peptide killed RPMI 8226 myeloma cells through a Bcl-B-dependent mechanism. Because Bcl-B is abundantly expressed in plasma cells and some myelomas, these findings raise the possibility of exploiting the Nur77/Bcl-B mechanism for apoptosis for eradication of autoimmune plasma cells or myeloma.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins / immunology
  • Apoptosis Regulatory Proteins / metabolism
  • Autoimmunity / drug effects
  • COS Cells
  • Cell Death / drug effects
  • Cell Death / immunology
  • Chlorocebus aethiops
  • DNA-Binding Proteins / immunology
  • DNA-Binding Proteins / metabolism
  • DNA-Binding Proteins / pharmacology*
  • Gene Expression Regulation, Neoplastic* / immunology
  • HeLa Cells
  • Humans
  • Multiple Myeloma / immunology
  • Multiple Myeloma / metabolism*
  • Multiple Myeloma / pathology
  • Nuclear Receptor Subfamily 4, Group A, Member 1
  • Peptides / immunology
  • Peptides / metabolism
  • Peptides / pharmacology*
  • Plasma Cells / immunology
  • Plasma Cells / metabolism*
  • Plasma Cells / pathology
  • Proto-Oncogene Proteins c-bcl-2 / immunology
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Receptors, Cytoplasmic and Nuclear / immunology
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Receptors, Steroid / immunology
  • Receptors, Steroid / metabolism
  • Transcription Factors / immunology
  • Transcription Factors / metabolism
  • Transcription Factors / pharmacology*

Substances

  • Apoptosis Regulatory Proteins
  • BCL2-like 10 protein
  • DNA-Binding Proteins
  • NR4A1 protein, human
  • Nuclear Receptor Subfamily 4, Group A, Member 1
  • Peptides
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Steroid
  • Transcription Factors